Assignee
MARUZEN PHARM CO LTD
JP·4 granted patents·11 pending applications·31 citations·filing 1998–2023
Top patents by PatentIndex Score
15 records- 0180US6022718AMethod of producing capsaicin analoguesMARUZEN PHARM CO LTD·Filed 1998·Granted Feb 8, 2000·31 cites·16 claims
- 0264US2025302784A1Myoblast proliferation promoter and myoblast-proliferation promoting composition, and muscle atrophy inhibitor and muscle-atrophy inhibiting compositionMARUZEN PHARM CO LTD·Filed 2023·Application pending·0 cites
- 0362US2025228806A1Ampk activator, motor function improving agent, muscular endurance improving agent, and muscle atrophy preventing agentMARUZEN PHARM CO LTD·Filed 2022·Application pending·0 cites
- 0459US2025186528A1Anti-obesity agent and anti-obesity compositionMARUZEN PHARM CO LTD·Filed 2023·Application pending·0 cites
- 0558US7910557B2Hair care productMARUZEN PHARM CO LTD·Filed 2009·Granted Mar 22, 2011·0 cites·7 claims
- 0654US2025302783A1Sympathetic nerve activation agent and sympathetic nerve activation compositionMARUZEN PHARM CO LTD·Filed 2023·Application pending·0 cites
- 0753US2025109416A1Method for producing 3-phenylpropionic acid analogue compoundsMARUZEN PHARM CO LTD·Filed 2023·Application pending·0 cites
- 0852US2025295618A1Parasympathetic nerve activation agent and parasympathetic nerve activation compositionMARUZEN PHARM CO LTD·Filed 2023·Application pending·0 cites
- 0952US2024252456A1Oral composition, skin cosmetic and hair cosmeticMARUZEN PHARM CO LTD·Filed 2022·Application pending·0 cites
- 1049US2023021051A1Composition Containing Black Ginger Extract and Composition for Oral AdministrationMARUZEN PHARM CO LTD·Filed 2020·Application pending·0 cites
- 1149US2013259952A1TIE2 Activator, Vascular Endothelial Growth Factor (VEGF) Inhibitor, Angiogenesis Inhibitor, Vascular Maturing Agent, Vascular Normalizing Agent and Vascular Stabilizing Agent, and Pharmaceutical CompositionMARUZEN PHARM CO LTD·Filed 2013·Application pending·0 cites
- 1244US2009054522A1Hair Care ProductMARUZEN PHARM CO LTD·Filed 2006·Application pending·0 cites
- 1343US12582146B2Angiotensin-converting enzyme inhibitor, blood pressure-lowering agent, and beverages and food productsMARUZEN PHARM CO LTD·Filed 2020·Granted Mar 24, 2026·0 cites·12 claims
- 1441US2015125542A1TIE2 Activator, Vascular Endothelial Growth Factor (VEGF) Inhibitor, Angiogenesis Inhibitor, Vascular Maturing Agent, Vascular Normalizing Agent and Vascular Stabilizing Agent, and Pharmaceutical CompositionMARUZEN PHARM CO LTD·Filed 2015·Application pending·0 cites
- 1536US10111920B2Salt-free miso production method, salt-free miso, hepatic function improvement agent, and hypertension improvement agentMARUZEN PHARM CO LTD·Filed 2015·Granted Oct 30, 2018·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when MARUZEN PHARM CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →